Home › Recently closed › 2026-09366
Drug Repurposing for Unmet Medical Needs; Request for Information
Read on FederalRegister.gov · Official PDF · Docket on Regulations.gov · Add to calendar (.ics)
Summary (from the Federal Register abstract)
The Food and Drug Administration (FDA, the Agency, or we) is opening a public docket to solicit input and comments on FDA's efforts with respect to drug repurposing to address unmet medical needs. FDA is requesting information on potential priority disease areas and potential candidates for drug repurposing, with a focus on FDA-approved drugs for which there appears to be no commercial interest in adding a new use through a supplement to a new drug application (supplemental application). Information provided through this public docket will help the Agency refine our efforts toward considering and evaluating candidates for drug repurposing.
- Document type
- Notice
- Federal Register document number
- 2026-09366
- Published
- May 12, 2026
- Action
- Notice; request for information; establishment of a public docket.
- Docket
- FDA-2026-N-4492
- Comments posted on Regulations.gov (at last check)
- 611
- DATES section (from the document)
- Submit either electronic or written comments, data, or information by June 11, 2026.
- Topics (auto-tagged)
- Other FDA topics
Source: Federal Register API, document 2026-09366. Federal Register text is a U.S. government work. Confirm dates in the official document; later documents may extend, reopen or correct them.